Advertisement

Pharmacologic Treatment of Sleep Disorders in Pregnancy

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Sleep Medicine Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Oyiengo D.
        • Louis M.
        • Hott B.
        • et al.
        Sleep disorders in pregnancy.
        Clin Chest Med. 2014; 35: 571-587
        • Hertz G.
        • Fast A.
        • Feinsilver S.H.
        • et al.
        Sleep in normal late pregnancy.
        Sleep. 1992; 14: 246-251
        • Fernandez-Alonso A.M.
        • Trabalon-Pastor M.
        • Chedraui P.
        • et al.
        Factors related to insomnia and sleepiness in the late third trimester of pregnancy.
        Arch Gynecol Obstet. 2012; 286: 55-61
        • Okun M.L.
        • Hanusa B.J.
        • Hall M.
        • et al.
        Sleep complaints in late pregnancy and the recurrence of postpartum depression.
        Behav Sleep Med. 2009; 7: 106-117
        • Lee K.A.
        • Gay C.L.
        Sleep in late pregnancy predicts length of labor and type of delivery.
        Am J Obstet Gynecol. 2004; 191: 2041-2046
        • Okun M.L.
        • Schetter C.D.
        • Glynn L.M.
        Poor sleep quality is associated with preterm birth.
        Sleep. 2011; 34: 1493-1498
        • Chen P.H.
        • Liou K.C.
        • Chen C.P.
        • et al.
        Risk factors and prevalence rate of restless legs syndrome among pregnant women in Taiwan.
        Sleep Med. 2012; 13: 1153-1157
        • Manconi M.
        • Govoni V.
        • De Vito A.
        • et al.
        Pregnancy as a risk factor for restless legs syndrome.
        Sleep Med. 2004; 5: 305-308
        • Manconi M.
        • Govoni V.
        • De Vito A.
        • et al.
        Restless legs syndrome in pregnancy.
        Neurology. 2004; 63: 1065-1069
        • Uglane M.T.
        • Westad S.
        • Backe B.
        Restless legs syndrome in pregnancy is a frequent disorder with a good prognosis.
        Acta Obstet Gynecol Scand. 2011; 90: 1046-1048
        • Lee K.A.
        • Zaffke M.E.
        • Baratte-Beebe K.
        Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron.
        J Womens Health Gend Based Med. 2001; 10: 335-341
        • Djaza A.
        • Wehrle R.
        • Lancel M.
        • et al.
        Elevated estradiol plasma levels in women with restless legs during pregnancy.
        Sleep. 2009; 32: 169-174
        • Scammell T.E.
        The neurobiology, diagnosis, and treatment of narcolepsy.
        Ann Neurol. 2003; 53: 154-166
        • Maurovat-Horvich E.
        • Kemlink D.
        • Hogl B.
        • et al.
        Narcolepsy and pregnancy: a retrospective European evaluation of 249 pregnancies.
        J Sleep Res. 2013; 22: 496-512
        • McAllister-Williams R.H.
        • Baldwin D.S.
        • Cantwell R.
        • et al.
        British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017.
        J Psychopharmacol. 2017; 31: 519-552
        • Iqbal M.M.
        • Sobhan T.
        • Ryals T.
        Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant.
        Psychiatr Serv. 2002; 53: 39-49
        • Hood S.D.
        • Norman A.
        • Hince D.A.
        • et al.
        Benzodiaze-pine dependence and its treatment with low dose flumazenil.
        Br J Clin Pharmacol. 2014; 77: 285-294
        • Ballinger B.R.
        New drugs. Hypnotics and anxiolytics.
        BMJ. 1990; 300: 456-458
        • Pollmann A.S.
        • Murphy A.L.
        • Bergman J.C.
        • et al.
        De- prescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review.
        BMC Pharmacol Toxicol. 2015; 16: 19
        • Koren G.
        • Pastuszak A.
        • Ito S.
        Drugs in pregnancy.
        N Engl J Med. 1998; 338: 1128-1137
        • Ban L.
        • West J.
        • Gibson J.E.
        • et al.
        First trimester expo sure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study.
        PLoS One. 2014; 9: e100996
        • Enato E.
        • Moretti M.
        • Koren G.
        The fetal safety of ben- zodiazepines: an updated meta-analysis.
        J Obstet Gynaecol Can. 2011; 33: 46-48
        • Saxen I.
        Associations between oral clefts and drugs taken during pregnancy.
        Int J Epidemiol. 1975; 4: 37-44
        • Safra M.J.
        • Oakley G.P.
        Association between cleft lip with or without cleft palate and prenatal exposure to diazepam.
        Lancet. 1975; 2: 478-480
        • Cates C.
        Benzodiazepine use in pregnancy and ma jor malformations or oral clefts. Pooled results are sensitive to zero transformation used.
        BMJ. 1999; 319: 918-919
        • Czeizel A.
        Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary.
        Reprod Toxicol. 1987; 1: 183-188
        • Rosenberg L.
        • Mitchell A.A.
        • Parsells J.L.
        • et al.
        Lack of relation of oral clefts to diazepam use during preg nancy.
        N Engl J Med. 1983; 309: 1282-1285
        • Wikner B.N.
        • Kallen B.
        Are hypnotic benzodiazepine receptor agonists teratogenic in humans?.
        J Clin Psychopharmacol. 2011; 31: 356-359
        • Sullivan S.S.
        • Guilleminault C.
        Emerging drugs for insomnia: new frontiers for old and novel targets.
        Expert Opin Emerg Drugs. 2009; 14: 411-422
        • Gunja N.
        The clinical and forensic toxicology of Z- drugs.
        J Med Toxicol. 2013; 9: 155-162
        • Siriwardena A.N.
        • Qureshi M.Z.
        • Dyas J.V.
        • et al.
        Magic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care.
        Br J Gen Pract. 2008; 58: 417-422
        • Huedo-medina T.B.
        • Kirsch I.
        • Middlemass J.
        • et al.
        Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration.
        BMJ. 2012; 345: e8343
        • Askew J.P.
        Zolpidem addiction in a pregnant woman with a history of second-trimester bleeding.
        Pharmacotherapy. 2007; 27: 306-308
        • Juric S.
        • Newport D.J.
        • Ritchie J.C.
        • et al.
        Zolpidem (Ambien) in pregnancy: placental passage and outcome.
        Arch Womens Ment Health. 2009; 12: 441-446
        • Diav-citrin O.
        • Okotore B.
        • Lucarelli K.
        • et al.
        Preg- nancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.
        Am J Perinatol. 1999; 16: 157-160
        • Wilton L.V.
        • Pearce G.L.
        • Martin R.M.
        • et al.
        The out- comes of pregnancy in women exposed to newly marketed drugs in general practice in England.
        Br J Obstet Gynaecol. 1998; 105: 882-889
        • Wikner B.N.
        • Stiller C.O.
        • Bergman U.
        • et al.
        Use of ben zodiazepines and benzodiazepine receptor ago nists during pregnancy: neonatal outcome and congenital malformations.
        Pharmacoepidemiol Drug Saf. 2007; 16: 1203-1210
        • Sharma A.
        • Sayeed N.
        • Khees C.R.
        • et al.
        High dose zolpidem induced fetal neural tube defects.
        Curr Drug Saf. 2011; 6: 128-129
        • Wang L.H.
        • Lin H.C.
        • Lin C.C.
        • et al.
        Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy.
        Clin Pharmacol Ther. 2010; 88: 369-374
        • Winokur A.
        • Gary K.A.
        • Rodner S.
        • et al.
        Depression, sleep physiology, and antidepressant drugs.
        Depress Anxiety. 2001; 14: 19-28
        • Wilt T.J.
        • Macdonald R.
        • Brasure M.
        • et al.
        Pharmaco- logic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the Amer- ican College of Physicians.
        Ann Intern Med. 2016; 165: 103-112
        • Djulus J.
        • Koren G.
        • Einarson T.R.
        • et al.
        Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
        J Clin Psychiatry. 2006; 67: 1280-1284
        • Wong J.
        • Motulsky A.
        • Abrahamowicz M.
        • et al.
        Off-la- bel indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
        BMJ. 2017; 356: j603
        • Mashiko H.
        • Niwa S.
        • Kumashiro H.
        • et al.
        Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: dose-finding study with no concomitant use of hypnotic agent.
        Psychiatry Clin Neurosci. 1999 Apr; 53: 193-194
        • Einarson T.R.
        • Einarson A.
        Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies.
        Pharmacoepidemiol Drug Saf. 2005; 14: 823-827
        • Tak C.R.
        • Job K.M.
        • Schoen-gentry K.
        • et al.
        The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retro spective database cohort studies.
        Eur J Clin Pharmacol. 2017; 73: 1055-1069
        • Huang H.
        • Coleman S.
        • Bridge J.A.
        • et al.
        A meta-anal- ysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight.
        Gen Hosp Psychiatry. 2014; 36: 13-18
        • Huybrechts K.F.
        • Bateman B.T.
        • Palmsten K.
        • et al.
        Anti- depressant use late in pregnancy and risk of persis- tent pulmonary hypertension of the newborn.
        JAMA. 2015; 313: 2142-2151
        • Smit M.
        • Dolman K.M.
        • Honig A.
        Mirtazapine in preg nancy and lactation - a systematic review.
        Eur Neuropsychopharmacol. 2016; 26: 126-135
        • Khazaie H.
        • Ghadami M.R.
        • Knight D.C.
        • et al.
        Insomnia treatment in the third trimester of pregnancy reduces postpartum depression symptoms: a randomized clinical trial.
        Psychiatry Res. 2013; 210: 901-905
        • De vries N.K.
        • Van der veere C.N.
        • Reijneveld S.A.
        • et al.
        Early neurological outcome of young infants exposed to selective serotonin reuptake inhibitors during pregnancy: results from the observational SMOK study.
        PLoS One. 2013; 8: e64654
        • Grigoriadis S.
        • Vonderporten E.H.
        • Mamisashvili L.
        • et al.
        The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis.
        J Clin Psychiatry. 2013; 74: e309-e320
        • Wisner K.L.
        • Sit D.K.
        • Hanusa B.H.
        • et al.
        Major depres- sion and antidepressant treatment: impact on preg- nancy and neonatal outcomes.
        Am J Psychiatry. 2009; 166: 557-566
        • Westin A.A.
        • Brekke M.
        • Molden E.
        • et al.
        Treatment with antipsychotics in pregnancy: changes in drug disposition.
        Clin Pharmacol Ther. 2018; 103: 477-484
        • Huybrechts K.F.
        • Hernández-Díaz S.
        • Patorno E.
        Anti- psychotic use in pregnancy and the risk for congen- ital malformations.
        JAMA Psychiatry. 2016; 73: 938-946
        • Cohen L.S.
        • Viguera A.C.
        • Mclnerney K.A.
        Reproductive safety of second-generation antipsychotics: current data from the Massachusetts General Hospital Na tional Pregnancy registry for atypical antipsychotics.
        Am J Psychiatry. 2016; 173: 263-270
        • Panchaud A.
        • Hernandez-Diaz S.
        • Freeman M.P.
        • et al.
        Use of atypical antipsychotics in pregnancy and maternal gestational diabetes.
        J Psychiatr Res. 2017; 95: 84-90
        • Sørensen M.J.
        • Kjaersgaard M.I.
        • Pedersen H.S.
        • et al.
        Risk of fetal death after treatment with antipsychotic medications during pregnancy.
        PLoS One. 2015 Jul 10; 10 (e0132280)
        • FDA
        FDA drug safety communication: antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns. In: FDA drug safety and availability.
        (Available at:) (Accessed October 1, 2017)
        • Tamura H.
        • Takasaki A.
        • Taketani T.
        • et al.
        Melatonin and female reproduction.
        J Obstet Gynaecol Res. 2014; 40: 1-11
        • Soliman A.
        • Lacasse A.A.
        • Lanoix D.
        • et al.
        Placental melatonin system is present throughout pregnancy and regulates villous trophoblast differentiation.
        J Pineal Res. 2015; 59: 38-46
        • Dubovicky M.
        • Ujhazy E.
        • Kovacovsky P.
        • et al.
        Effect of melatonin on neurobehavioral dysfunctions induced by intrauterine hypoxia in rats.
        Cent Eur J Public Health. 2004; 12: S23-S25
        • Dominguez Rubio A.P.
        • Correa F.
        • Aisemberg J.
        • et al.
        Maternal administration of melatonin exerts short- and long-term neuroprotective effects on the offspring from lipopolysaccharide-treated mice.
        J Pineal Res. 2017; https://doi.org/10.1111/jpi.12439
        • Davis F.C.
        Melatonin: role in development.
        J Biol Rhythms. 1997; 12: 498-508
        • Einarson A.
        • Bailey B.
        • Jung G.
        • et al.
        Prospective controlled study of hydroxyzine and cetirizine in pregnancy.
        Ann Allergy Asthma Immunol. 1997; 78: 183-186
        • Serreau R.
        • Komiha M.
        • Blanc F.
        • et al.
        Neonatal sei- zures associated with maternal hydroxyzine hydro- chloride in late pregnancy.
        Reprod Toxicol. 2005; 20: 573-574
        • Diav-Citrin O.
        • Shechtman S.
        • Aharonovich A.
        Preg- nancy outcome after gestational exposure to lorata- dine or antihistamines: a prospective controlled cohort study.
        J Allergy Clin Immunol. 2003; 111: 1239-1243
        • Li Q.
        • Mitchell A.A.
        • Werler M.M.
        • et al.
        Assessment of antihistamine use in early pregnancy and birth defects.
        J Allergy Clin Immunol Pract. 2013; 1: 666-674
        • Nageotte M.P.
        • Briggs G.G.
        • Towers C.V.
        • et al.
        Droperi- dol and diphenhydramine in the management of hy- peremesis gravidarum.
        Am J Obstet Gynecol. 1996; 174: 1801-1805
        • Gilboa S.M.
        • Strickland M.J.
        • Olshan A.F.
        • et al.
        Use of antihistamine medications during early preg- nancy and isolated major malformations.
        Birth Defects Res A Clin Mol Teratol. 2009; 85: 137-150
        • Silber M.H.
        • Becker P.M.
        • Earley C.
        • et al.
        Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome.
        Mayo Clin Proc. 2013; 88: 977-986
        • Andersohn F.
        • Garbe E.
        Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot- derived dopamine agonists.
        Mov Disord. 2009; 24: 129-133
        • Garcia-Borreguero D.
        • Ferini-strambi L.
        • Kohnen R.
        • et al.
        European guidelines on management of rest less legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the Euro pean Sleep Research Society.
        Eur J Neurol. 2012; 19: 1385-1396
        • Lipford M.C.
        • Silber M.H.
        Long-term use of pramipex- ole in the management of restless legs syndrome.
        Sleep Med. 2012; 13: 1280-1285
        • Cornelius J.R.
        • Tippmann-Peikert M.
        • Slocumb N.L.
        • et al.
        Impulse control disorders with the use of dopa- minergic agents in restless legs syndrome: a case- control study.
        Sleep. 2010; 33: 81-87
        • Picchietti D.L.
        • Hensley J.G.
        • Bainbridge J.L.
        • et al.
        Consensus clinical practice guidelines for the diag- nosis and treatment of restless legs syndrome/Willis- Ekbom disease during pregnancy and lactation.
        Sleep Med Rev. 2015; 22: 64-77
        • Dostal M.
        • Weber-schoendorfer C.
        • Sobesky J.
        • et al.
        Pregnancy outcome following use of levodopa, pra- mipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series.
        Eur J Neurol. 2013; 20: 1241-1246
        • Araujo B.
        • Belo S.
        • Carvalho D.
        Pregnancy and tumor outcomes in women with prolactinoma.
        Exp Clin Endocrinol Diabetes. 2017; 125: 642-648
        • Costa Gdr A.
        • Galvao T.C.
        • Bacchi A.D.
        • et al.
        Inves tigation of possible teratogenic effects in the offspring of mice exposed to methylphenidate dur ing pregnancy.
        Reprod Biomed Online. 2016; 32: 170-177
        • Peters H.T.
        • Strange L.G.
        • Brown S.S.D.
        • et al.
        The phar macokinetic profile of methylphenidate use in preg nancy: a study in mice.
        Neurotoxicol Teratol. 2016; 54: 1-4
        • Haervig K.B.
        • Mortensen L.H.
        • Hansen A.V.
        • et al.
        Use of ADHD medication during pregnancy from 1999 to 2010: a Danish register-based study.
        Pharmacoepidemiol Drug Saf. 2014; 23: 526-533
        • Diav-Citrin O.
        • Shechtman S.
        • Arnon J.
        • et al.
        Methyl- phenidate in pregnancy: a multicenter, prospective, comparative, observational Study.
        J Clin Psychiatry. 2016; 77: 1176-1181
        • Newport D.J.
        • Hostetter A.L.
        • Juul S.H.
        • et al.
        Prenatal psychostimulant and antidepressant exposure and risk of hypertensive disorders of pregnancy.
        J Clin Psychiatry. 2016; 77: 1538-1545
        • Calvo-Ferrandiz E.
        • Peraita-Adrados R.
        Narcolepsy with cataplexy and pregnancy: a case-control study.
        J Sleep Res. 2017; https://doi.org/10.1111/jsr.12567
        • Kuczkowski K.M.
        Liquid ecstasy during pregnancy.
        Anaesthesia. 2004; 59: 926